Polyneuropathy, Inflammatory Demyelinating, Chronic
Neurology·MeSH: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Prevalence
5.0 / 100K
2 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Frequently asked questions
How many drugs are in development for Polyneuropathy, Inflammatory Demyelinating, Chronic?
BioSniper tracks 2 drugs in development for Polyneuropathy, Inflammatory Demyelinating, Chronic across 1 company.
How many clinical trials target Polyneuropathy, Inflammatory Demyelinating, Chronic?
There are 3 clinical trials targeting Polyneuropathy, Inflammatory Demyelinating, Chronic tracked by BioSniper.
What is the prevalence of Polyneuropathy, Inflammatory Demyelinating, Chronic?
The estimated prevalence of Polyneuropathy, Inflammatory Demyelinating, Chronic is approximately 5.0 per 100,000 population.
Deep-dive into Polyneuropathy, Inflammatory Demyelinating, Chronic
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis